MET and gastric carcinoma: The receptor tyrosine kinase RON is a member of c-MET proto-oncogene family and a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma; 56.1% of gastric carcinomas exhibit high expression of both RON and RONΔ165, leading to a poor survival rate [16,38].